According to a statement from the pharmaceutical company to the stock exchanges, the Import Alert implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with CGMP standards.
Mumbai (Maharashtra) [India], May 30 (ANI): Sun Pharmaceuticals Industries on Monday reported a consolidated net loss of Rs 2,227.38 crore for the quarter ended March 2022 as against a net profit of Rs 848 crore recorded in the corresponding period of the previous year, hit by one-time charg
Mumbai (Maharashtra) [India], Feb 13 (ANI): Sun Pharmaceutical Industries has registered gross sales of Rs 7,657 crore in the quarter ending December 2018, marking 16 per cent growth over the same quarter in previous year.